NCT00079131: Oblimersen in Treating Patients With Merkel Cell Carcinoma |
|
|
| Completed | 2 | 37 | US | oblimersen sodium, augmerosen, G3139, G3139 bcl-2 antisense oligodeoxynucleotide, Genasense, pharmacological study, pharmacological studies, laboratory biomarker analysis | National Cancer Institute (NCI) | Recurrent Neuroendocrine Carcinoma of the Skin, Stage I Neuroendocrine Carcinoma of the Skin, Stage II Neuroendocrine Carcinoma of the Skin, Stage III Neuroendocrine Carcinoma of the Skin, Stage IV Neuroendocrine Carcinoma of the Skin | 01/07 | | | |
NCT01200342: Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma |
|
|
| Terminated | 2 | 7 | US | Genasense, G3139, Oblimersen, Paclitaxel, Taxol, Carboplatin, Paraplatin | M.D. Anderson Cancer Center, Genta Incorporated | Melanoma | 09/13 | 09/13 | | |
